Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive PatientsGradman AH, Schmieder RE, Lins RL, et al (Western Pennsylvania Hosp, Pittsburgh; Univ of Erlangen-Nürnberg, Germany; Jan Palfijn-Gallifort, Mer